# GPR119 Agonist for Hypoglycemia in Type 1 Diabetes

> **NCT04432090** · PHASE2 · COMPLETED · sponsor: **AdventHealth Translational Research Institute** · enrollment: 110 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Placebo
- **DRUG:** Study Medication (MBX-2982)
- **OTHER:** No medication for this group

## Key facts

- **NCT ID:** NCT04432090
- **Lead sponsor:** AdventHealth Translational Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-21
- **Primary completion:** 2023-08-12
- **Final completion:** 2023-08-12
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04432090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04432090, "GPR119 Agonist for Hypoglycemia in Type 1 Diabetes". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04432090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*